HomeONPPF • OTCMKTS
add
Oncopeptides AB
Previous close
$0.27
Year range
$0.27 - $0.60
Market cap
141.65M SEK
Avg Volume
7.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 9.91M | 85.76% |
Operating expense | 92.52M | 9.00% |
Net income | -83.43M | -2.73% |
Net profit margin | -841.50 | 44.70% |
Earnings per share | — | — |
EBITDA | -82.72M | -3.78% |
Effective tax rate | -0.95% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 178.54M | 2.94% |
Total assets | 244.19M | 2.44% |
Total liabilities | 189.91M | 4.58% |
Total equity | 54.28M | — |
Shares outstanding | 215.19M | — |
Price to book | 1.06 | — |
Return on assets | -73.96% | — |
Return on capital | -97.13% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -83.43M | -2.73% |
Cash from operations | -71.50M | -29.07% |
Cash from investing | 496.00K | 49,700.00% |
Cash from financing | -2.06M | 63.10% |
Net change in cash | -71.48M | -18.76% |
Free cash flow | -46.22M | -81.40% |
About
CEO
Founded
2000
Website
Employees
80
